New York University

Puretech Health, LLC

Puretech Lyt, Inc.

Aleksandra Filipovic

George Miller

Joseph Beene Bolen

Eric Elenko

Shohei Koide

Akiko Koide

Linxiao Chen

Takamitsu Hattori

Tatyana Panchenko

Joseph Bolen

Disclosed herein are antibodies specific to a delta-1 chain of a γδ T cell receptor and methods of using such for modulating γδ T cell bioactivity. Such anti-Delta 1 antibodies may also be used to treat diseases associated with γδ T cell activation, such as solid tumors, or for detecting presence of γδ1 T cells.

Antibodies specific to delta 1 chain of T cell receptor

Disclosed herein are anti-Galectin-9 antibodies and methods of using such for inhibiting a signaling pathway mediated by Galectin-9 or eliminating pathologic cells expressing Galectin-9. Such anti-Galectin-9 antibodies may also be used to diagnose and/or to treat diseases associated with Galectin-9, such as autoimmune diseases and solid tumors.

Anti-galectin-9 antibodies and uses thereof

Anti-Galectin-9 antibodies and uses thereof

Growing community of inventors

London, United Kingdom

Aleksandra Filipovic